Collaborating and Sharing Ideas
Throughout its history, the LRA has played a pivotal role in bringing together the key players in the fight...
Stories & News
Positive Results on Anifrolumab for Lupus Published in New England Journal of Medicine
December 18, 2019
The Lupus Research Alliance (LRA) welcomes additional positive results published today in the New England Journal of...
Congress Set to Double Funds for Lupus Research Thanks to LRA Advocates
December 16, 2019
Lupus Research Alliance advocates have good reason to pat themselves on the back today! The 2020 Defense...
2019 Lupus Insight Prize Awarded to Ignacio Sanz, MD
Thinking outside the box” is jargon that often rings hollow—but not so when it’s used to describe the ideas...
Leading with Extraordinary Clarity and Grace
Leading with Extraordinary Clarity and Grace
The LRA is enormously grateful to Mary K. (Peggy) Crow, MD for her more...
Lupus News Corner
BIG … BOLD … IDEAS ARE TRANSFORMING LUPUS RESEARCH—thanks to people like you!
Thanks to our remarkable supporters, the Lupus...
2019: A Year of Tremendous Growth
The Lupus Research Alliance (LRA) boldly pursued breakthroughs on the many fronts of lupus research in 2019—allowing the organization...
Moving Forward with Incredible Success
Taking a Closer Look at 2019
In the course of the year, the Lupus Research Alliance (LRA) took daring chances,...
Great News for Lupus Nephritis Treatment: Itolizumab Fast-Tracked by FDA
December 10, 2019
The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by...
Lupus Research Alliance Applauds Phase III Trial Results for Potential Lupus Nephritis Treatment
December 4, 2019
The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase III trial results for...
Positive Study Results in Potential Treatment for Cutaneous and Systemic Lupus
December 3, 2019
The Lupus Research Alliance (LRA) is pleased to share positive results reported by Biogen Inc. from the...
LRA Researchers Star at ACR/ARP – Part 2
Last week we gave you only half the story of what scientists funded by the Lupus Research Alliance (LRA)...